|
CDK4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.11180000003952E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.22069999999963E-05 |
| Normal-vs-Stage2 |
2.284400E-01 |
| Normal-vs-Stage3 |
1.087210E-01 |
| Normal-vs-Stage4 |
2.158700E-04 |
| Stage1-vs-Stage2 |
1.896590E-01 |
| Stage1-vs-Stage3 |
8.216300E-02 |
| Stage1-vs-Stage4 |
4.452300E-02 |
| Stage2-vs-Stage3 |
9.932600E-01 |
| Stage2-vs-Stage4 |
1.361890E-02 |
| Stage3-vs-Stage4 |
6.441900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.11280000000014E-05 |
| Normal-vs-AfricanAmerican |
4.396200E-03 |
| Normal-vs-Asian |
7.016300E-02 |
| Caucasian-vs-AfricanAmerican |
4.960000E-01 |
| Caucasian-vs-Asian |
1.619380E-01 |
| AfricanAmerican-vs-Asian |
2.573400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.36160000000641E-05 |
| Normal-vs-Female |
1.961900E-04 |
| Male-vs-Female |
6.547200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.869740E-02 |
| Normal-vs-Age(41-60Yrs) |
3.582000E-04 |
| Normal-vs-Age(61-80Yrs) |
2.041600E-04 |
| Normal-vs-Age(81-100Yrs) |
3.751800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.787760E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.080600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.696180E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.943400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.173000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.695200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.863700E-03 |
| Normal-vs-Grade 2 |
6.584800E-04 |
| Normal-vs-Grade 3 |
7.058200E-03 |
| Normal-vs-Grade 4 |
1.976280E-04 |
| Grade 1-vs-Grade 2 |
6.095000E-01 |
| Grade 1-vs-Grade 3 |
4.375600E-01 |
| Grade 1-vs-Grade 4 |
1.124180E-01 |
| Grade 2-vs-Grade 3 |
8.981600E-01 |
| Grade 2-vs-Grade 4 |
1.459960E-02 |
| Grade 3-vs-Grade 4 |
1.584140E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.411640E-01 |
| Normal-vs-ccB subtype |
3.82589999999849E-05 |
| ccA subtype-vs-ccB subtype |
7.218100E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.415700E-04 |
| Normal-vs-N1 |
2.040500E-02 |
| N0-vs-N1 |
1.037010E-01 |
|
|
